Loading company…
Ribopeutic develops small molecule drugs that target RNA.
Established in 2022, Ribopeutic develops small molecule drugs targeting RNA. The company is based in Hangzhou, China. In March 2025, it raised Series A funding from Heda Venture.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in